Updated

Boston Scientific disclosed that a cyberattack, rather than any shortfall in device demand or product performance, forced the company to cut its financial guidance. The disclosure clarifies that the medical device maker's underlying business fundamentals remain intact despite the guidance reduction. The incident highlights growing cybersecurity risk exposure among health care device makers, with investors parsing the disruption's financial impact separately from core commercial performance.